Canada Langer-founded biotech raises $38M for once-daily obesity pill Last updated: July 1, 2025 8:25 pm By Hannah Green Share 0 Min Read Langer-founded biotech raises $38M for once-daily obesity pill SHARE The Boston biotech has secured $33 million in venture capital and $5 million in NIH funding to advance its once-daily obesity pill. Share This Article Email Copy Link Print Previous Article Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma’s Global Partnership Is Strong Tailwind Next Article Binance’s CZ donated $10M in BNB to Vitalik Buterin’s biotech efforts SearchSearch Judge Rejects TikTok’s Bid to Dismiss New Hampshire Lawsuit Business Canada XRP News Today: XRP Surges 26% to $2.80 on Whale Activity and ETF Buzz Canada XRP FDA Voucher Reforms: A Golden Opportunity in Biotech Valuations Canada Now, Emirates Partners with Crypto to Introduce Cryptocurrency Payment Option, Here’s All You Need To Know – Travel And Tour World Canada
